Clinical Trial Update: Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Clinical trial update evaluating switching from insulin therapy to a metformin and saxagliptin combination in patients with Type 2 diabetes mellitus (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: ikfe-CRO GmbH | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN